Additionally, in an AD mouse model, pharmacological inhibition of hexokinase 2 (HK2), a key glycolytic enzyme, increased LPL expression, which in turn regulated lipid metabolism and was associated with reduced amyloid load and improved cognitive function [75]. The gene discussed is HK1; the disease is Alzheimer disease.